Introduction: Even though ocular refractive state is highly heritable and under strong genetic control, the identification of susceptibility genes remains a challenge. Several (hepatocyte growth factor) gene variants have been associated with ocular refractive errors and corneal pathology.
Purpose: Here, we assess the association of an gene variant, previously reported as associated with hyperopia, and ocular biometric parameters in a multicenter Spanish cohort.
Graves' ophthalmopathy (GO) is an autoimmune inflammatory disorder associated with thyroid disease which affects ocular and orbital tissues. GO follows a biphasic course in which an initial active phase of progression is followed by a subsequent partial regression and a static inactive phase. Although the majority of GO patients have a mild, self-limiting, and nonprogressive ocular involvement, about 3-7% of GO patients exhibit a severe sight-threatening form of the disease due to corneal exposure or compressive optic neuropathy.
View Article and Find Full Text PDFAim: To compare the mydriatic efficacy of an ophthalmic insert (Mydriasert, MY) versus phenylephrine and tropicamide (PT) eye drops.
Methods: Two controlled, prospective, randomized, single-blind studies were performed. In the first study, a total of 80 eyes from 40 outpatient-clinic patients were analyzed.
Purpose: To analyze the changes in incision sizes after implantation of a toric intraocular lens (IOL) using 2 methods.
Setting: Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
Design: Prospective case series.